Interventions for hirsutism (excluding laser and photoepilation therapy alone)

EJ van Zuuren, Z Fedorowicz… - Cochrane Database …, 2015 - cochranelibrary.com
Background Hirsutism occurs in 5% to 10% of women of reproductive age when there is
excessive terminal hair growth in androgen‐sensitive areas (male pattern). It is a distressing …

Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with …

H Zhao, C **ng, J Zhang, B He - Reproductive health, 2021 - Springer
Background Multiple oral insulin-sensitizing agents, such as metformin, thiazolidinediones,
inositols, and berberine, have been proven safe and efficacious in improving the endocrine …

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

JM Melin, M Forslund, SJ Alesi, T Piltonen… - Clinical …, 2024 - Wiley Online Library
Objective Characteristic features of polycystic ovary syndrome (PCOS) include insulin
resistance and an increased risk for type 2 diabetes. To promote improved insulin sensitivity …

Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments

EJ Van Zuuren, Z Fedorowicz - British Journal of Dermatology, 2016 - academic.oup.com
Hirsutism is a common disorder with a major impact on quality of life. The most frequent
cause is polycystic ovary syndrome. Effects of interventions (except laser and light‐based …

An evaluation of the available pharmacotherapy for the treatment of hirsutism

L Asfour, A Kazmi, R Sinclair - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction Hirsutism is the presence of excessive body hair in a male pattern distribution in
a woman, and can affect up to 20% of women. It can be associated with high levels of …

Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized …

MA Abdalla, N Shah, H Deshmukh… - Clinical …, 2022 - Wiley Online Library
Context Polycystic ovary syndrome (PCOS) is a heterogeneous condition affecting women of
reproductive age and is associated with increased body weight. Objective To review the …

Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of …

MA Abdalla, N Shah, H Deshmukh, A Sahebkar… - Archives of Gynecology …, 2023 - Springer
Context Polycystic ovary syndrome (PCOS) is a complex endocrine disease that affects
women of reproductive age and is characterised by biochemical and clinical androgen …

[PDF][PDF] Comparative E cacy of Oral Insulin Sensitizers Metformin, Thiazolidinediones, Inositol, and Berberine in Improving Endocrine and Metabolic Pro les in Women …

H Zhao, C **ng, J Zhang, B He - scholar.archive.org
Background Multiple oral insulin-sensitizing agents, such as metformin, thiazolidinediones,
inositols, and berberine, have been proven safe and e cacious in improving the endocrine …

Development of a structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome

H Mani - 2014 - figshare.le.ac.uk
Background: Polycystic ovary syndrome (PCOS) is a chronic condition with a reported
prevalence of up to 18% and is associated with adverse long term outcomes. Structured …